Back to TVTX
Candriam S.C.A. TVTX Position History
Travere Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$27.3M
Q3 2026
Peak value
$27.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $12.3M |
| Q4 2025 | $17.9M |
| Q4 2025 | $17.9M |
| Q1 2026 | $11M |
| Q2 2026 | $26.7M |
| Q3 2026 | $27.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $27.3M | 461.3K | — | — |
| Q2 2026 | $26.7M | 470.3K | — | — |
| Q1 2026 | $11M | 370.0K | — | — |
| Q4 2025 | $17.9M | 468.6K | — | — |
| Q4 2025 | $17.9M | 468.6K | — | — |
| Q3 2025 | $12.3M | 512.7K | — | — |
Other funds holding TVTX
$241.8M
$241.8M
$218.9M
$147.4M
$104.1M